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ABSTRACT
The main goal of Systems Biology research is to reconstruct biological networks for its topological
analysis so that reconstructed networks can be used for the identification of various kinds of disease. The
availability of high-throughput data generated by microarray experiments fuelled researchers to use
whole-genome gene expression profiles to understand cancer and to reconstruct key cancer-specific gene
regulatory network. Now, the researchers are taking a keen interest in the development of algorithm for
the reconstruction of gene regulatory network from whole genome expression profiles. In this study, a
cancer-specific gene regulatory network (prostate cancer) has been constructed using a simple and novel
statistics based approach. First, significant genes differentially expressing them self in the disease
condition has been identified using a two-stage filtering approach t-test and fold-change measure. Next,
regulatory relationships between the identified genes has been computed using Pearson correlation
coefficient. The obtained results has been validated with the available databases and literatures. We
obtained a cancer-specific regulatory network of 29 genes with a total of 55 regulatory relations in which
some of the genes has been identified as hub genes that can act as drug target for the cancer diagnosis.
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1. INTRODUCTION
Microarray technology allows researchers to measure the expressions of large numbers
(thousands) of genes simultaneously. In human body, all cells contain same genetic material but
the same genes may or may not be active. This variation in the activation of genes assists
researchers to understand more about the function of the cells. Microarray technology helps
researchers to get insight about many different diseases such as various cancer disease, heart
disease, mental illness, and infectious disease, etc. [1]. Gene regulation refers to processes in
which cells are used to create functional gene products (such as RNA, proteins) from the
information stored in genes (DNA). Gene expression data is used widely for the analysis of
disease and its diagnosis. Microarray gene expression data is playing a significant role in cancer
predication and diagnosis. These data can be characterized by many variables (genes) which are
measured on only a few observations (experiments) due to experimental limitations [1]. This
provides great opportunities to explore large scale regulatory networks for various purposes such
as to identify specific genes causing particular disease so that researchers can target those genes
to understand interactions among transcription factors and drug targets, to understand
metabolism, and so on [2].
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Gene regulatory networks (GRNs) are the systematic biological networks that describe
interactions among genes in the form of a graph, where node represents genes and edges their
regulatory interactions. Understanding the GRNs helps in understanding interactions among
genes, biological and environmental effects and to identify the target genes for drug against the
diseases [3]. GRNs have been proved to be a very useful tool used to describe and explain
complex dependencies between key developmental transcription factors (TFs), their target genes
and regulators [4][5]. Reconstruction of GRN is the development of network model from the
available datasets. The GRN reconstruction explicitly represents the developmental or regulatory
process, which is of great interest today. Reconstruction has become a challenging computational
problem for researchers to understand complex regulatory mechanisms in biological systems.
Although, every methods for inferring GRNs from microarray gene expression profiles have both
strengths and weaknesses. In this study, we constructed and analysed prostate cancer GRN.
Prostate cancer is a slow growing cancer that develops in the prostate and it can spread to other
parts of the body such as bones and lymph nodes. It has been reported that prostate cancer is the
second leading cause of cancer-related death in United States [6] and sixth in the world [7]. This
cancer is most common in developed countries with growing rates in development countries.
Monitoring of gene expression from microarray is considered to be one of the most promising
techniques for the discovery of GRNs. This technique making GRNs feasible. However,
inferring GRNs from time series microarray gene expression  involves following challenges i)
number of related genes is very large compared to the number of samples or time points, ii)
observed data involves  a significant amount of noise, and iii) gene interactions  displays
complex (nonlinear and dynamic) relationships [2,3,8,9].
2. RELATED WORKS
The gene regulatory network models can be used to enhance the understanding of gene
interactions and explicate the environmental and drug effects. Gene regulatory networks models
can mainly be categorized into two types that use discrete and continuous variables [5,10]. The
models that use discrete types of variables assume that genes exist in discrete state only. Boolean
variables implement these types of approximation in which genes are either in active state (1) or
inactive state (0). The Boolean networks are not realistic because some information loss occurs
during discretization [11,5]. Bayesian models implements the discretization of variables. These
models estimate the probability relationship between genes in the network. The structure of these
types of GRNs is modeled by a directed acyclic graph (DAG) in which the expression level, its
conditional dependencies on parent and it’s probability distribution of particular gene are
estimated. These networks are unsuitable for handling time series gene expression or temporal
information [5,11,12,13]. The models that uses continuous variables and got most popular are
based on ordinary differential equations (ODEs). It models the concentrations of RNAs, proteins,
and other molecules with nonnegative real number values of variable. The disadvantage of
numerical techniques is the lacking the measurements of the kinetic parameters in the rate
equations [5,13]. Most of the earlier work on reconstruction of GRN has been done on smaller
organisms having small genome. A few attempt has been made to reconstruction GRN of human
related disease. Wang and Gotoh [27] inferred directed cancer-specific GRN using soft
computing rules from microarray data. They studied Colon Cancer datasets consisting of 2000
genes and 62 samples and analyzed 18 annotated genes only. Basso et al. [28] report the
reconstruction of gene regulatory networks from gene expression profiles of human B cells. The
results show a scale-free network, where a few hub genes were identified. Jiang et al [29]
identified multiple disease pathways in which genes extracted by supervised learning of the
genome-wide transcriptional profiles for patients and normal samples. A pair-wise relevance
metric, adjusted frequency value, was applied to describe the degree of genetic relationship
between two molecular determinants. The methodology was applied to analyze microarray
dataset of colon cancer and results demonstrate that the Colon Cancer-specific gene network
captures the most central genetic interactions. The topological analysis of inferred network
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shows three known hub cancer genes. An extensive review on GRN modelling can be found in
[8, 4, 11, 14, 13, 10]. In the present study, we tried to identify hub (highly connected) genes and
analyze the topological behaviour of the constructed network in prostate cancer datasets.
3. MATERIALS AND METHODS
To find regulatory relationship between gene pairs using gene expression profile, many
techniques have been used in the literature. In this work, Pearson's correlation coefficient has
been applied.  The main steps of the proposed algorithm are outlined as follows.
(1) Preprocessing of the dataset
(2) Identification of most significant genes
(3) Finding regulatory relationship between gene pairs
(4) Elimination of weak correlation
(5) Visualization of the network
(6) Biological validation
(7) Topological analysis
2.1. Preprocessing of Datasets
The gene expression data are mostly present in normalized form. The normalized data for each
gene are typically known as an ‘expression ratio’ or as the logarithm of the expression ratio. The
expression ratio for a particular gene is basically the normalized value of the expression level
which is the ratio of query sample and its normalized value for the control. The datasets under
consideration are in normalized form. We did data preprocessing to handle missing values,
duplicate and missing gene names, etc in the datasets.
2.2. Identification of Most Significant Genes
In this step, those genes are identified that are differentially expressing themselves in diseased
condition. A two-stage filtering strategy has been applied in this paper. At the first stage,
statistical measure t-test has been applied. The t-test for unpaired data and both for equal and
unequal variance  can be computed as,
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where xi and yi are the means, gi and hi are the variances, and n1 and n2 are the sizes of the two
groups of the samples (conditions) tissue and cultured , respectively, of gene expression profile i.
At the second stage, a fold-change strategy has been applied. A fold change is a measure that
describes how much expression level of a gene changes over two different samples (conditions)
or groups. The fold change (FC) for linear data can be calculated as,
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where, xi and yi are mean of gene expression profile i in tissue and cultured cases, respectively. In
case, gene expression data is already in Log2 transformed form, fold change can be computed as
[15],
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2.3. Finding Regulatory Relationship Between Gene Pairs
We applied Pearson correlation coefficient rxy to find out regulatory relationship between gene
pairs x and y. The correlation is +1 if there is a perfect positive linear relationship, −1 if there is a
perfect negative linear relationship and values between −1 and 1 indicates the degree of linear
dependence between the variables. Closer the coefficient to either −1 or +1, stronger the
correlation between the variables. If the coefficient is zero, the variables are independent. If we
have n samples (conditions) of x and y genes, written as xi and yi where i = 1, 2, ..., n, the
correlation coefficient between x and y (rxy) can be estimated as,
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Once, the pair-wise correlation coefficient between genes are computed, next we select those
coefficient having absolute values above a threshold and eliminated weakly correlated gene
pairs. This strategy allows to focus on a few highly connected genes. In this study, we observed
that only few genes are strongly correlated, mostly positively and few negatively. The pair-wise
correlation among rest of the gene pairs are pretty week.
4. RESULTS AND DISCUSSIONS
In this study, microarray data of prostate cancer has been taken for network construction and its
topological analysis [30]. The dataset (the full dataset can be downloaded from GEO
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE26126) consists of 27575 genes,
having 181 tissue and 12 cultured samples. To find out the most significant genes, a two-stage
filtering has been applied. In the first stage, the statistical test two-tailed t-test is applied to find
out the significant genes and considered only those genes having p-value<=0.001 as significant
genes and extracted it for the analysis. Out of the 27575 genes from the dataset,  9985 genes have
been extracted on the basis of p-value, which is approximately 36% of total number of genes.
The formula to calculate t-statistic for unpaired data and both for equal and unequal variance is
given in equation (1). In the next stage, we applied a fold-change measure to evaluate the
changes in expression level of each gene. The fold change for two kind of data can be calculated
using equation (3).  At this stage, we considered only those genes showing a minimum of five-
fold change in expression-level and finally 101 genes has been selected, which is 0.01 % of 9985
genes (extracted at first stage) and 0.003% of total 27575 genes.
Further, Pearson correlation has been applied and observed the pair-wise correlation among
extracted 101 genes. The Pearson correlation can be calculated using equation (4).  The week
correlation between gene pairs has been dropped. The correlation absolute value which are
>=0.85 has been considered as strong correlation and thus, 55 regulatory relationship has been
identified which involves 29 genes only. This strategy again reduced the noise level of data up to
0.001% of total of 27575 genes.
Finally, 29 extracted genes has been validated with available biological databases and literatures.
Most of the genes among 29 are somehow involved in prostate cancer. The Table 1 shows
validation of individual genes and their family from various biological databases and literature.
The Table 2 shows the interaction of gene pairs and representing either the relation is activation
(+) or repressing (−) .The positive (+) correlation shows activation and negative value (−) shows
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repressing (inhibiting). Out of 55 extracted regulatory relations, 52 are activators and only 3 are
inhibitors.
Table 1. List of genes found to be involved in prostate cancer.
Genes Brief description Reference(s)
GAS6 family, MYO3A overexpressed in androgen-independent
compared to androgen-dependent prostate
cancer cells
A P. Singh, et al. (2008)
[16]
S100A16 family,
PSMD1, RND2,  PLAT,
PPP3R1family
under-expressed in androgen-independent
compared to androgen-dependent  prostate
cancer cells
A P. Singh, et al. (2008)
[16]
KCNS2, SLC17A8
family, COL17A1
family
Potential secretory biomarkers for selenium
action in prostate cancer
Hongjuan Zhao (2004)
[17]
PHLDA1 Changes in Expression in benign prostatic
in benign prostatic  hyperplasia (BPH)
Hongjuan Zhao, et al
(2004) [17]
KRT5 marker of basal cells in prostate glands Uma R Chandran, et al.
(2007) [18]
CA9 gene of C4-2 prostate cancer cell line which
is being expressed
Asa J Oudes, et al.
(2005) [19]
SLAMF9 SLAMF9 is subfamily of CD2 which in
association with EWI subfamily to
inversely correlates with metastasis
potential of prostate cancer
Xin A. Zhang, et al.
(2003) [20]
AQP10 expression and cellular localization of the
AQPs were determined in the human
prostate cancer
Insang Hwang, et al.
(2012) [21]
BNIP3 overexpressed in various tumors, including
prostate cancer.
Xueqin Chen, et al.
(2010) [22]
ZFAND2B Zinc finger, AN1-type domain 2B
expressed in prostate cancer and many more
tissues
G2SBC Database [23]
SRPX2 the nucleic acid that encodes a SRPX2 can
be act as target for cancer like prostate
cancer.
IMHOF, et al. (2007)
[24]
CSTF1 186-gene “invasiveness” gene signature
(IGS) including CSTF1 are not only
associated with only breast cancer but also
in many cancer cells such as prostate
cancer, etc.
Rui Liu, (2007) [25]
KCNE2 KCNQ1 form complex with KCNE2 family
and regualtes in prostate cancer
NCBI [26]
At the next step the network has been constructed using Cytoscape software tool which is shown
in Fig. 1. From the constructed network in Fig. 1, we can easily identify that genes KRT5,
BNIP3, GJB5 and KCNE2 are participating as hub genes with former three having total degree
(indegree and outdegree) of eight, and later having total degree of six. GJB5 is activating seven
other genes SLAMF9, PAK6, COL17A1, HCAR2, C8A, S100A16 and KRT5, and GJB5 is
activated by other hub gene KCNE2. Similarly, gene KCNE2 activates six other genes GJB5,
SLAMF9, COL17A1, HCAR2, PAK6 and KRT5. The gene CSTF1 does not activate any other
gene rather it is activated by EMP1 and inhibited by two other genes SRPX2 and hypothetical
LOC401459. The hypothetical LOC401459 inhibits only CSTF1, activated by SRPX2 and
inhibited by EMP1. There are many genes that do not regulate (either activate or inhibit) any
other genes in the network such as PSMD1, CSTF1, ZFAND2B, BNIP3, PLAT, C8A and
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HCAR2. From the Fig. 1 it is clear that gene BNIP3 is activated by large number of genes and
hence it will be overexpressed. From the literature [22] it has been proved that gene BNIP3 is
overexpressed in various tumors including prostate. The other identified hub gene KRT5 is a
marker of basal cells in prostate glands and  shows uniform downregulation in all metastatic
tumors [18]. From the literature [26], it has been validated that KCNQ1 form complex with
KCNE2 (also one of the identified hub gene) family and regulates in prostate cancer.
Table 2. List of genes found to be involved in prostate cancer.
Source Target Activate (+)Repress (−)
GJB5
SLAMF9 +
PAK6 +
COL17A1 +
HCAR2 +
C8A +
S100A16 +
KRT5 +
KCNE2
GJB5 +
SLAMF9 +
COL17A1 +
HCAR2 +
PAK6 +
KRT5 +
S100A16
PAK6 +
PHLDA1 +
C8A +
PLAT +
ZNF577
RND2 +
SLC17A8 +
GAS6 +
BNIP3 +
GAS6
RND2 +
BNIP3 +
SLC17A8 +
PAK6 +
KRT5
PAK6 +
BNIP3 +
ST18 +
COL17A1
BNIP3 +
C8A +
HCAR2 +
AQP10
SLC17A8 +
ST18 +
RND2 +
EMP1
SRPX2 +
CSTF1 +
hypothetical LOC401459 −
PPP3R1 ZFAND2B +YWHAH +
CA9 S100A16 +AQP10 +
SRPX2 hypothetical LOC401459 +CSTF1 −
SLC17A8 RND2 +BNIP3 +
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PAK6 BNIP3 +RND2 +
RND2 BNIP3 +
PHLDA1 PLAT +
YWHAH PSMD1 +
KCNS2 SLC17A8 +
SLAMF9 HCAR2 +
MYO3A RND2 +
C8A PAK6 +
hypothetical LOC401459 CSTF1 −
Figure 1. Inferred gene regulatory network of 29 genes and 55 regulatory relations using proposed
methodology. The finding shows that genes KRT5, BNIP3, GJB5 and KCNE2 are participating as hub
genes.
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5. CONCLUSIONS
The complex molecular interactions underlying cancer is due to the perturbations in the gene
regulatory networks. Therefore, identification of cancerous genes, pathways control by them
through gene regulatory networks is a key step towards cancer diagnosis. A directed regulatory
network is proficient to reveal interactions among genes more legitimately and also capable to
capture cause-effect relations between genes-pairs. This paper reports a simple statistical
approach to extract differentially expressed genes, finding correlations between gene-pairs for
the reconstruction of gene regulatory networks under specific disease conditions that assist the
interpretability of the network. First, genes relevant to a specific cancer using a t-test and fold-
change method has been identified. The pair-wise correlation coefficients among gene pairs were
calculated and a threshold value has been imposed to eliminate weakly correlated gene pairs and
found 55 significantly correlated gene pairs that involves 29 genes. A regulatory network has
been constructed using Cytoscape software tool. During the analysis of the constructed network
we observed that some genes are working as hub genes including KRT5, BNIP3, GJB5 and
KCNE2. Among them, BNIP3 is highly activated (overexpressed) gene which has been proved
to be overexpressed in prostate cancer [22]. The other hub gene KRT5 is a marker of basal cells
in prostate glands and shows uniform downregulation in all metastatic tumors [18]. The result
shows that gene KCNE2 regulate large number of genes which can be validated with [26] that it
regulates in prostate cancer.
The regulatory relationships among genes in cancer are not freely accessible from database and
available in literature. Due to this problem, the construction of gene regulatory networks and
their validation in a realistic manner is really a difficult task. The utility and reliability of our
study needs further experimental validation. Our finding can help to reveal common molecular
interactions in the cancer under study and provide new insights in cancer diagnostics, prognostics
and therapy. Our proposed approach can also be used to investigate other disease specific gene
regulatory network like colon cancer, lung cancer, breast cancer and so on. In future study, we
will try to construct regulatory networks for other types of cancer from microarray data.
Microarray data are inherently noisy due to experimental limitations. Noises in the dataset
directly reflects the statistical techniques. Today, artificial intelligence based approach such as
fuzzy logic, neural networks, evolutionary computation are being used in many bioinformatics
research problems. The promises of fuzzy logic to tolerate noise and deal with impression, neural
network to learn from data rich environment and evolutionary computation for the optimization
can be good candidate to infer gene regulatory network from microarray data. In the future, we
can apply these artificial intelligence based sophisticated techniques to better construct cancer-
specific regulatory networks.
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